Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

Sector archive

Published briefings for one sector.

Browse recent results from companies in the same sector.

All briefingsConsumerHealthcareTransport & InfrastructurePrimary IndustriesPropertyInvestment CompaniesTechnologyConstruction & Materials
Open archive
Clear filters

Showing 25-48 of 81 published briefings.

Ryman Healthcare (RYM)•FY25•Released 29 May 2025

EBITDAF tripled to $45.5m but NPAT loss widened to -$436.8m

Operating recovery is overshadowed by a capex surge to 70.4% of revenue and a -$94.2m free cash outflow.

Published 28 April 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•FY25•Released 28 May 2025

Operating cash flow more than doubled to $548.6m as capex normalised

Revenue crossed $2.0bn for the first time and FCF reached 113.3% of NPAT, signalling earnings backed by cash after years of heavy capex.

Published 22 April 2026

Read briefing→
Oceania Healthcare (OCA)•FY25•Released 22 May 2025

Capex jumped 354% to $132.4m, pushing FCF to -$22.1m

EBITDA rose 4.1% and a tax credit held NPAT, but a major capex step-up consumed operating cash and net debt sits at 7.2x EBITDA.

Published 22 April 2026

Read briefing→
BLIS Technologies (BLT)•FY25•Released 22 May 2025

NPAT up 33% as operating cash flow jumped 70% on receivables release

Earnings grew on operating leverage and cash conversion strengthened to 178%, but 73% of NPAT and nearly all operating cash flow landed in the second

Published 22 April 2026

Read briefing→
Radius Residential Care (RAD)•FY25•Released 21 May 2025

PBT rose 191.7% to $10.5m as margins and cash conversion stepped up

Margin and cash-conversion gains look durable, but a prior-year tax distortion exaggerates the NPAT swing from a $8.5m loss to a $7.0m profit.

Published 23 April 2026

Read briefing→
Summerset Group Holdings (SUM)•FY24•Released 28 February 2025

Underlying profit up 8% but development margin slipped and net debt grew NZ$322m

Statutory NPAT fell 22.1% on smaller fair-value gains while gross borrowings rose 23% to fund a NZ$611.4m build programme.

Published 23 April 2026

Read briefing→
EBOS Group (EBO)•HY25•Released 19 February 2025

NPAT fell 18.9% on a 9.0% revenue decline as dividend held flat

Operating deleverage pushed the NPAT payout ratio to 100.2% while net debt to EBITDA crept up to 3.86x even as cash conversion rebounded.

Published 22 April 2026

Read briefing→
Ryman Healthcare (RYM)•HY25•Released 28 November 2024

PBT up 21.9% but NPAT fell 49.4% on a tax-rate flip

A tax line that flipped from +30.2% to -46.0% drove the NPAT divergence while pre-lease free cash flow stayed below the historical range at -$52.5m.

Published 28 April 2026

Read briefing→
Green Cross Health (GXH)•HY25•Released 28 November 2024

FCF jumped to $23.1m on debtor release while ROE slipped to 3.3%

NPAT was flat at $5.6m and returns sat below the historical baseline as a $4.9m receivables drawdown drove most of the cash uplift.

Published 22 April 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•HY25•Released 28 November 2024

FPH PBT up 46.8% as capex normalisation swings FCF positive

Operating leverage delivered above-baseline earnings growth while capex falling 80% to NZ$55.1m rebuilt FPH into a net cash position.

Published 22 April 2026

Read briefing→
Pacific Edge (PEB)•HY25•Released 26 November 2024

Revenue fell 16.3% with under a year of cash at current burn rate

Loss narrowed just 4.9% despite a smaller cost base, leaving $21.9m of cash against a $12.5m half-year operating burn.

Published 22 April 2026

Read briefing→
Blis Technologies (BLT)•HY25•Released 26 November 2024

Blis returned to profit with 25.4% revenue growth and NZ$0.7m OCF

HY25 swung from a NZ$0.7m loss to a NZ$0.2m profit, but the prior year's heavy second-half skew sets a demanding bar for FY25.

Published 22 April 2026

Read briefing→
Radius Residential Care (RAD)•HY25•Released 25 November 2024

PBT up 75% but reported EBITDA fell 8.1% on a care home sale

Net debt cut 25% and cash conversion improved, but a 94.2% payout sits against a $0.07m cash balance and a higher tax rate.

Published 23 April 2026

Read briefing→
Oceania Healthcare (OCA)•HY25•Released 22 November 2024

Underlying EBITDA up 2.7% but reported result swung to NZ$17.1m NPAT loss

Operating cash flow surged on a NZ$101m receivables collection while items below EBITDA pushed PBT down 160.3% to a NZ$19.5m loss.

Published 22 April 2026

Read briefing→
Summerset Group Holdings (SUM)•HY24•Released 26 August 2024

Revenue up 18.2% but PBT fell 5.7% on 520bps development margin compression

A surge in development capex to $255.6m flipped free cash flow to -$63.9m and pushed net debt to $1,527.3m despite stronger occupation-rights cash

Published 23 April 2026

Read briefing→
EBOS Group (EBO)•FY24•Released 21 August 2024

NPAT up 7.1% but operating cash flow fell 11% and leverage climbed to 1.68x

Cash conversion slid to 57.5% from 68.8% while the full-year dividend absorbed roughly 99.1% of free cash flow, tightening financial headroom.

Published 22 April 2026

Read briefing→
Green Cross Health (GXH)•FY24•Released 30 May 2024

Net cash flipped to $11.5m net debt as continuing PBT fell 17.3%

Operating cash held flat but reserves fell $34.8m and borrowings rose 48.5%, with the final dividend cut 42.9% to 2.0 cents.

Published 22 April 2026

Read briefing→
Promisia Healthcare (PHL)•FY24•Released 29 May 2024

PBT surged on a 25.6% revenue lift driven by prior-year acquisition

Revenue growth of 25.6% flatters the comparison because FY23 included a major acquisition, while a negative effective tax rate of -54.6% inflates

Published 19 May 2026

Read briefing→
Radius Residential Care (RAD)•FY24•Released 29 May 2024

EBITDA up 47% but NPAT loss widened on tax distortion

Operating earnings and leverage improved sharply, but a 335.8% effective tax rate turned PBT of $3.6m into an $8.5m net loss.

Published 23 April 2026

Read briefing→
Oceania Healthcare (OCA)•FY24•Released 24 May 2024

Capex cut 68% to manage 7.7x leverage; tax benefit inflated NPAT

EBITDA rose just 3.2% on 7.4% revenue growth, while a -10.9% effective tax rate drove NPAT up 104.5% and development capex was paused.

Published 22 April 2026

Read briefing→
Blis Technologies (BLT)•FY24•Released 24 May 2024

Blis returns to profit on 12.6% revenue growth, but H2 carried the year

FY24 NPAT of $0.6m swung from a $1.3m loss on 18.2% B2B growth, with the first half a $0.7m loss and the second half doing all the work.

Published 22 April 2026

Read briefing→
Pacific Edge (PEB)•FY24•Released 21 May 2024

Revenue rose 21.9% but losses widened 9.5% with cash down to $29.3m

Cash burn held near $25.8m while equity eroded 34% to $54.6m, leaving runway as the central question on a still loss-making business.

Published 22 April 2026

Read briefing→
Rua Bioscience (RUA)•HY24•Released 29 February 2024

Goodwill impairment of $8.3m drives HY24 loss of $10.9m

Management writes off a prior acquisition that failed to deliver, leaving a $1.0m cash buffer and ongoing operating burn.

Published 28 April 2026

Read briefing→
Summerset Group Holdings (SUM)•FY23•Released 26 February 2024

NPAT up 62.1% but underlying profit grew just 11.0% on revaluation gains

Underlying profit of NZ$190.3m and 1,103 ORA sales describe a steadier operational result than the headline IFRS NPAT, while net debt rose NZ$332m.

Published 23 April 2026

Read briefing→
←Previous page
1
2
3
4
Next page→

Get reporting-season briefings

Get full NZX result briefings by email as new coverage is published.